API Guidelines on Immunizations during COVID 19 Pandemic.

J Assoc Physicians India

Member of Governing Body, The Association of Physicians of India.

Published: June 2020

Download full-text PDF

Source

Publication Analysis

Top Keywords

api guidelines
4
guidelines immunizations
4
immunizations covid
4
covid pandemic
4
api
1
immunizations
1
covid
1
pandemic
1

Similar Publications

Background: Pseudomonas aeruginosa is a major cause of healthcare-associated infections (HAIs), particularly in immunocompromised patients, leading to high morbidity and mortality rates. This study aimed to investigate the antimicrobial resistance patterns, virulence gene profiles, and genetic diversity among P. aeruginosa isolates from hospitalized patients in Mazandaran, Iran.

View Article and Find Full Text PDF

Breast cancer is one of the most common malignant tumors in women worldwide. Although large language models (LLMs) can provide breast cancer nursing care consultation, inherent hallucinations can lead to inaccurate responses. Retrieval-augmented generation (RAG) technology can improve LLM performance, offering a new approach for clinical applications.

View Article and Find Full Text PDF

Bruton's tyrosine kinase inhibitors (BTKis) exhibit significant interindividual pharmacokinetics, making therapeutic drug monitoring (TDM) a promising approach for personalized therapy. However, simultaneous quantification of multiple BTKis poses technical challenges. A unified protocol for BTKis detection would be clinically desirable.

View Article and Find Full Text PDF

Pharmaceutical excipients are indispensable components of drug formulations, playing critical roles in enhancing stability, improving bioavailability, and ensuring patient compliance. In pediatric and geriatric populations, the selection of these excipients becomes even more crucial due to their unique physiological and pharmacokinetic profiles, as well as age-specific formulation requirements. This review examines the functions, safety considerations, and potential adverse effects of excipients in these vulnerable groups.

View Article and Find Full Text PDF

Nitrosamine impurities have been classified as probable human carcinogens for decades. These impurities were reported in water, food, tobacco, pesticides, and plastics but received attention in mid-2018 when N-nitrosodimethylamine (NDMA) was reported in valsartan drug products. Subsequently, it was revealed that several small molecule and complex nitrosamine impurities can form in any active pharmaceutical ingredient (API) or drug product in which secondary or tertiary amines are present (as API or as impurities) along with a nitrosating agent.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!